Appropriate solution selection at the administering epirubicin hydrochloride to the breast cancer patients

被引：2
|
作者：
Masuda, N. [1 ]
Amani, S. [2 ]
Nishikata, M. [3 ]
Matsuyama, K. [3 ]
Tsujinaka, T. [1 ]
机构：
[1] Osaka Natl Hosp, Osaka, Japan
[2] Sakai Municipal Hosp, Sakai, Osaka, Japan
[3] Mukogawa Womens Univ, Sch Pharmaceut Sci, Ashiya, Japan
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)90912-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
309
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [31] Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer
    Yeo, W
    Mok, TSK
    Tse, KK
    Kwan, WH
    Lam, KC
    Ho, WM
    Chiu, SKW
    Chan, ATC
    Leung, TWT
    Mo, FKF
    Johnson, PJ
    ANTI-CANCER DRUGS, 2002, 13 (06) : 655 - 662
  • [32] Differential effects of epirubicin and docetaxel on the immune system in patients with breast cancer (BC).
    Wimmer, Kerstin
    Sachet, Monika
    Birnleitner, Hanna
    Exner, Ruth
    Filipits, Martin
    Gnant, Michael
    Fitzal, Florian
    Oehler, Rudolf
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
    Velasco-Ruiz, Alejandro
    Nunez-Torres, Rocio
    Pita, Guillermo
    Wildiers, Hans
    Lambrechts, Diether
    Hatse, Sigrid
    Delombaerde, Danielle
    Van Brussel, Thomas
    Alonso, M. Rosario
    Alvarez, Nuria
    Herraez, Belen
    Vulsteke, Christof
    Zamora, Pilar
    Lopez-Fernandez, Teresa
    Gonzalez-Neira, Anna
    PHARMACEUTICS, 2021, 13 (11)
  • [34] A COMPARATIVE-STUDY OF DOXORUBICIN AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER
    HORTOBAGYI, GN
    YAP, HY
    KAU, SW
    FRASCHINI, G
    EWER, MS
    CHAWLA, SP
    BENJAMIN, RS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 57 - 62
  • [35] Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
    Andrea Michelotti
    Marco Venturini
    Carmelo Tibaldi
    Carmelo Bengala
    Luigi Gallo
    Flavio Carnino
    Lucia Del Mastro
    Rita Lionetto
    Elda Montanaro
    Riccardo Rosso
    Pierfranco Conte
    Breast Cancer Research and Treatment, 2000, 59 : 133 - 139
  • [36] Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
    Teresa Mele
    Daniele Generali
    Stephen Fox
    Maria Pia Brizzi
    Alessandra Bersiga
    Manuela Milani
    Giovanni Allevi
    Simone Bonardi
    Sergio Aguggini
    Marco Volante
    Luigi Dogliotti
    Alberto Bottini
    Adrian Harris
    Alfredo Berruti
    Breast Cancer Research and Treatment, 2010, 123 : 795 - 804
  • [37] Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer
    Ichinose, Ichiro
    Hamada, Yuzo
    Mitsuyama, Shoshu
    Ishikawa, Emi
    Ikeda, Tadashi
    Kobayashi, Sunao
    Horikoshi, Noboru
    Tamura, Kazuo
    CHEMOTHERAPY, 2008, 54 (05) : 379 - 385
  • [38] Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin
    Kenichiro Nagata
    Nobuaki Egashira
    Takaaki Yamada
    Hiroyuki Watanabe
    Yui Yamauchi
    Ryozo Oishi
    Supportive Care in Cancer, 2012, 20 : 951 - 955
  • [39] Venlafaxine hydrochloride as treatment of hot flashes in patients with breast cancer
    Membrini, F
    Giardina, G
    Chini, C
    Masera, LR
    Pinotti, G
    ANNALS OF ONCOLOGY, 2000, 11 : 45 - 45
  • [40] A Phase I Study of Ixabepilone in Combination With Epirubicin in Patients With Metastatic Breast Cancer
    Roche, Henri
    De Benedictis, Elena
    Cottura, Ewa
    Govi, Silvia
    Dalenc, Florence
    Locatelli, Alberta
    Deslandres, Marion
    Zambetti, Milvia
    Gladieff, Laurence
    Messina, Marianne
    Gianni, Luca
    CLINICAL BREAST CANCER, 2012, 12 (03) : 167 - 174
12345